CHARLES A BAKER

CIK 1225470 · last filed 2018-01-03

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$5.51M

Companies

2

Total Filings

36

Lifetime Open-Market Net

-$28.15M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
REGN Director 9,000 $612.14 $5.51M -$28.08M 29 2018-01-03
PROGENICS PHARMACEUTICALS INC (PGNX) Delisted Director 21,481 -$75.0K 7 2012-06-14

Recent Filings · Page 2 of 4

36 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2013-10-02 REGN Mixed -$4.42M EDGAR
2013-06-12 REGN Mixed -$3.54M EDGAR
2013-01-03 REGN Grant (A) $0 EDGAR
2012-11-27 REGN Mixed −1,100 -$2.48M EDGAR
2012-09-06 REGN Mixed -$2.02M EDGAR
2012-06-14 PROGENICS PHARMACEUTICALS INC (PGNX) Delisted Grant (A) $0 EDGAR
2012-04-19 REGN Mixed -$1.59M EDGAR
2012-01-04 REGN Grant (A) $0 EDGAR
2011-08-11 REGN Exer (M) +4,000 $115.2K EDGAR
2011-07-06 PROGENICS PHARMACEUTICALS INC (PGNX) Delisted Grant (A) $0 EDGAR
Showing 1120 of 36
Page 2 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.